Eli Lilly & Co.

The article recommends investing $1,000 in either the State Street SPDR S&P 500 ETF Trust (SPY) or eight individual stocks, including Nvidia Corp., Alphabet Inc., and Apple Inc., based on CFRA's analysis and implied upside percentages. Analyst Angelo Zino highlights growth potential in AI and cloud computing for companies like Nvidia and Alphabet.

Novo Nordisk CEO Mike Doustdar highlights the potential of the company's obesity drugs, such as Ozempic and Wegovy, to impact longevity and other healthcare areas beyond weight loss. The drugs' active ingredient, semaglutide, shows possible benefits for organ protection and slowing aging-related processes, even before significant weight loss. Investors are urging the company to diversify as competitors like Eli Lilly expand into broader markets.